HOTAIRM1 and central nervous system cancer: Moreover, they showed increased expression of HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) and decreased expression of RFPL1 antisense RNA 1 (RFPL1S) as the malignancy progressed; i.e., in glioblastoma compared to low-grade glioma and the reference samples.